Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute/National Institute of Health
Grant: R21CA256462
National Cancer Institute/National Institute of Health
Grant: R01CA258682
National Cancer Institute/National Institute of Health
Grant: F110796
National Cancer Institute/National Institute of Health
Grant: CCR18548498
National Cancer Institute/National Institute of Health
Grant: 1W81XWH-21-1-0053
NIH HHS
Grant: R211CA256462; R01CA258682
National Institutes of Health
Grant: 1R01CA258682-01A1
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
National Institutes of Health
Grant: 5R21CA256462-02
Targeting of eIF4A along with immunotherapy to overcome chemoresistance
Fields of Study
Keywords